具体和敏感干预措施对受结核病影响的人群社会保护的影响:元分析
Melisane Regina Lima Ferreira1, Jesús David Cortés Gil2, Rubia Laine de Paula Andrade3
1University of Sao Paulo at Ribeirao Preto College of Nursing, Ribeirao Preto, Sao Paulo, Brazil. melisanerlf@usp.br.
社会保护干预措施显著提高了结核病治疗成功率. 结核病特异性和结核病敏感性计划都有利于患者,突出显示了纳入公共卫生政策的必要性.
科学领域:
- 公共卫生 公共卫生
- 社会干预 社会干预
- 结核病研究 结核病研究
背景情况:
- 社会保护干预措施分为结核病特异性或结核病敏感性.
- 结核病特定干预措施被整合到结核病治疗计划中.
- 对结核病敏感的干预措施是对一般人口更广泛的社会保护的一部分.
研究的目的:
- 进行对社会保护干预措施对受结核病影响的人在治疗期间的影响进行元分析.
- 评估结核病特异性和结核病敏感性的社会保护战略.
主要方法:
- 对报告赔率比率 (OR) 和/或相对风险 (RR) 的研究进行元分析.
- 根据人群和干预类型对影响的分类.干预类型.
- 使用I2统计数据和通过网络道图表发布偏差来评估异质性.
- 使用乔安娜·布里格斯研究所建议的方法质量评估.
主要成果:
- 包括13篇文章与82,602名参与者;干预侧重于有条件的现金转移.
- 结核病特异性 (影响估计2.16) 和结核病敏感性 (影响估计1.15) 干预措施都对治疗成功产生了积极影响.
- 具体干预措施对治疗结果产生了更强烈的积极影响.
结论:
- 社会干预措施对结核病治疗结果产生积极影响.
- 研究结果支持将社会保护纳入结核病控制计划.
- 结果强调了社会干预在结核病流行地区的公共政策中的作用,解决贫困和社会排斥问题.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
相关概念视频
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
